Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers

Chemotherapy

Volumn 45, Issue 6, 1999, Pages 491-495

  Davy, Maria ^a   Bird, Nicholas ^a   Rost, Karl Ludwig ^b   Fuder, Hermann ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b PAREXEL INTERNATIONAL   (United States)

Author keywords

Drug interaction; Fluoroquinolone; Gemifloxacin; Pharmacodynamics; Warfarin

Indexed keywords

GEMIFLOXACIN; PROTHROMBIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAM; FLATULENCE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RASH; STEADY STATE;

EID: 0032711950     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007243     Document Type: Article

References (14)

1. Serlin MJ, Breckenridge AM: Drug interactions with warfarin. Drugs 1983;25:610-620.
2. Hermans JJR, Thijssen HHW: Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics. Br J Pharmacol 1993;110:482-490.
3. Miners JO, Birkett DJ: Cytochrome P4502C9: An enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 1998;45: 525-538.
4. Randinitis EJ, Koup JR, Bron NJ, Hounslow NJ, Rausch G, Abel R, Vassos AB, Sedman AJ: Drug interaction studies of clinafloxacin (CLX) and probenecid, cimetidine, phenytoin and warfarin. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998, San Diego, CA, USA. Poster A-20.
5. Efthymiopoulos C: Pharmacokinetics of grepafloxacin. J Antimicrob Chemother 1997;40(suppl A):35-43.
6. Liao S, Palmer M, Fowler C, Nayak RK: Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers. J Clin Pharm 1996;36:1072-1077.
7. Bianco TM, Bussey HI, Farnett LE, Linn WD, Rousch MK, Wong YW: Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation. Pharmacotherapy 1992;12:435-439.
8. Janknegt R: Drug interactions with quinolones. J Antimicrob Chemother 1990;26(suppl D):7-29.
9. Marchbanks CR: Drug-drug interactions with fluoroquinolones. Pharmacotherapy 1993;13:23S-28S.
10. Moore T, Niconovich N, Coleman K: SB-265805 (LB20304a): In vitro antibacterial activity against the common respiratory tract pathogens Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998, San Diego, CA, USA. Poster F-098.
11. Critchley IA, Broskey J, Coleman K: SB-265805 (LB20304a): In vitro activity, intracellular accumulation and killing of Legionella pneumophila in human macrophages. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998, San Diego, CA, USA. Poster F-100.
12. Smirnov A, Wellmer A, Gerber J, Maier K, Henne S, Nau R: Gemifloxacin is effective in experimental pneumococcal meningitis. 10th European Congress of Clinical Microbiology and Infectious Diseases, 1999, Berlin, Germany. Poster 223.
13. Allen A, Bygate E, Teillol-Foo M, Oliver S, Johnson M, Ward C: Pharmacokinetics and tolerability of gemifloxacin after administration of single oral doses to healthy volunteers; in: Abstracts from the 21st International Congress of Chemotherapy, Birmingham, UK. J Antimicrob Chemother 1999;44(suppl A): 137:Poster 440.
14. Allen A, Bygate E, Teillol-Foo M, Oliver S, Johnson M, Ward C: Multiple-dose pharmacokinetics and tolerability of gemifloxacin following oral doses to healthy volunteers; in: Abstracts from the 21st International Congress of Chemotherapy, Birmingham, UK. J Antimicrob Chemother 1999;44(suppl A):133:Poster 418.